Cutaneous manifestations of endocrine disorders: A guide for dermatologists

American Journal of Clinical Dermatology

Volumn 4, Issue 5, 2003, Pages 315-331

  Jabbour, Serge A ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; AMINOGLUTETHIMIDE; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCITRIOL; CALCIUM; FLUDROCORTISONE; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; INSULIN; KETOCONAZOLE; LEVOTHYROXINE; METFORMIN; METYRAPONE; ORAL CONTRACEPTIVE AGENT; PREDNISOLONE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; SEX HORMONE; SPIRONOLACTONE; THIAMAZOLE; THIAZOLIDINE DERIVATIVE; THYROID HORMONE; VASOPRESSIN;

ACROMEGALY; ADDISON DISEASE; AGRANULOCYTOSIS; ARTHRALGIA; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CUSHING DISEASE; DIAGNOSTIC TEST; DOSE RESPONSE; DRUG EFFECT; ENDOCRINE DISEASE; FEVER; GRAVES DISEASE; HUMAN; HYPOPITUITARISM; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; IODINE DEFICIENCY; LABORATORY TEST; MEDICAL SPECIALIST; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; PRACTICE GUIDELINE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PRURITUS; RASH; REVIEW; SKIN DISEASE; SURGICAL TECHNIQUE; THYROTOXICOSIS; TREATMENT OUTCOME; URTICARIA; VOMITING;

ACROMEGALY; ADDISON DISEASE; CUSHING SYNDROME; DERMATOLOGY; DIABETES COMPLICATIONS; ENDOCRINE SYSTEM DISEASES; HUMANS; HYPERPARATHYROIDISM; HYPERPIGMENTATION; HYPOPITUITARISM; HYPOTHYROIDISM; PRACTICE GUIDELINES; SKIN DISEASES; THYROTOXICOSIS;

EID: 0038031616     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200304050-00003     Document Type: Review

References (104)

1. Brownlie BE, Wells JE. The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in North Canterbury, 1983-1985. Clin Endocrinol 1990; 33 (2): 249-59
2. Reinwein D, Benker G, Konig MP, et al. The different types of hyperthyroidism in Europe: results of a prospective study of 924 patients. J Endocrinol Invest 1988; 11 (3): 193-200
3. Williams I, Ankrett VO, Lazarus JH, et al. Aetiology of hyperthyroidism in Canada and Wales. J Epidemiol Community Health 1983; 37 (3): 245-8
4. Dabon-Almirante CLM, Surks MI. Clinical and laboratory diagnosis of thyrotoxicosis. Endocrinol Metab Clin North Am 1998; 27 (1): 25-35
5. Mullin GE, Eastern JS. Cutaneous signs of thyroid disease. Am Fam Physician 1986; 34 (4): 93-8
6. Holt PJA, Lazarus J, Marks R. The epidermis in thyroid disease. Br J Dermatol 1976; 95: 513-8
7. Rosen T, Kleman GA. Thyroid and the skin. In: Callen JP, Jorizzo JL Greer KE, et al., editors. Dermatologic signs of internal disease. 2nd ed. Philadelphia: WB Saunders, 1995: 189
8. Heymann WR. Cutaneous manifestations of thyroid disease. J Am Acad Dermatol 1992; 26: 885-902
9. Freinkel RK. Cutaneous manifestations of endocrine diseases. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al., editors. Dermatology in general medicine. 4th ed. New York: McGraw-Hill, 1993: 2113-31
10. Rook A. Endocrine influences on hair growth. BMJ 1965; 1: 609-14
11. Rook A, Dawber R. Diseases of the hair and scalp. 2nd ed. Oxford: Blackwell Scientific Publications, 1991: 147
12. Norton LA. Disorders of the nails. In: Moschella SL, Hurley HJ, editors. Dermatology. 3rd ed. Philadelphia: WB Saunders, 1992: 1574
13. Locke W. Unusual manifestations of Graves' disease. Med Clin North Am 1967; 51 (4): 915-24
14. Mullin GE, Eastern JS. Cutaneous consequences of accelerated thyroid function. Cutis 1986; 37: 109-14
15. Davis PJ, Davis FB. Hyperthyroidism in patients over the age of 60 years. Medicine 1974; 53 (3): 161-81
16. Heymann WR. The skin in thyrotoxicosis. In: Braverman LE, Utiger RD, editors. The thyroid. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 593-5
17. Ortonne J-P, Mosher DB, Fitzpatrick TB. Vitiligo and other hypomelanoses of hair and skin. New York: Plenum, 1983: 182
18. Cunliffe WJ, Hall R, Newell DJ, et al. Vitiligo, thyroid disease and autoimmunity. Br J Dermatol 1968; 80: 135-9
19. Shong YK, Kim JA. Vitiligo in autoimmune thyroid disease. Thyroidology 1991; 3: 89-91
20. Kantor GR, Bernhard JD. Investigation of the pruritic patient in daily practice. Semin Dermatol 1995; 14: 290-6
21. Readett MD. Constitutional eczema and thyroid disease. Br J Dermatol 1964; 76: 126-39
22. Collet E, Petit J-M, LaCroix M, et al. Chronic urticaria and thyroid auto-immunity. Ann Dermatol Venereol 1995; 122 (6-7): 413-6
23. Pegum JS, Grice K. Unusual skin eruptions with eosinophilia associated with hyperthyroidism. Br J Dermatol 1973; 88 (3): 295-301
24. Thomson JA. Xanthelasma associated with thyrotoxicosis. J Clin Endocrinol Metab 1965 (Pt 1); 25: 758-60
25. Fatourechi V, Pajouhi M, Fransway AF. Dermopathy of Graves' disease (pretibial myxedema): review of 150 cases. Medicine 1994; 73 (1): 1-7
26. Horiuchi Y. Pretibial myxedema associated with chronic thyroiditis [letter]. Arch Dermatol 1985; 121 (4): 451
27. McDougall IR. Graves' disease: current concepts. Med Clin North Am 1991; 75: 79-95
28. Moule B, Grant MC, Boyle IT, et al. Thyroid acropachy. Clin Radiol 1970; 21: 329-33
29. Solanki SV, Shah SS, Kothari UR. Thyroid acropachy. Indian J Med Sci 1973; 27: 708-10
30. Ross DS. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am 2001; 30 (2): 245-64
31. Ladenson PW. Diagnosis of thyrotoxicosis. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's the thyroid. 7th ed. Philadelphia: Lippincott-Raven, 1996: 708-12
32. Kaplan MM, Meier DA, Dworkin HJ. Treatment of hyperthyroidism with radioactive iodine. Endocrinol Metab Clin North Am 1998; 27 (1): 205-23
33. Cooper DS. Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease. Endocrinol Metab Clin North Am 1998; 27 (1): 225-47
34. Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab Clin North Am 1998; 27 (1): 169-85
35. Braverman LE, Utiger RD. Introduction to hypothyroidism. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's the thyroid. 7th ed. Philadelphia: Lippincott-Raven, 1996: 736-7
36. Larsen PR, Davies TF, Hay ID. The thyroid gland. In: Wilson JD, Foster DW, Kronenberg HM, et al, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998: 460-6
37. Bernhard JD, Freedberg IM, Vogel LN. The skin in hypothyroidism. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's the thyroid. 7th ed. Philadelphia: Lippincott-Raven, 1996: 792-5
38. Wayne EJ. Clinical and metabolic studies in thyroid disease. BMJ 1960; 1: 78-90
39. Diven DG, Gwinup G, Newton RC. The thyroid. Dermatol Clin 1989; 7: 547-58
40. Al-Jubouri MA, Coombes EJ, Young RM, et al. Xanthoderma: an unusual presentation of hypothyroidism. J Clin Pathol 1994; 47 (9): 850-1
41. Orteu CH, Rustin MH. 20 thickened, fragile nails. Lancet 1996; 347 (9002): 662
42. Tosti A, Baran R, Dawber RPR. The nail in systemic diseases and drug-induced changes. In: Baran R, Dawber RPR, editors. Diseases of the nails and their management. 2nd ed. Oxford: Blackwell Scientific Publications, 1994: 175
43. Cunningham MJ, Zone JJ. Thyroid abnormalities in dermatitis herpetiformis: prevalence of clinical thyroid disease and thyroid autoantibodies. Ann Intern Med 1985; 102 (2): 194-6
44. Stockigt JR. Free thyroid hormone measurement. Endocrinol Metab Clin North Am 2001; 30 (2): 265-89
45. Ladenson PW. Diagnosis of hypothyroidism. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's the thyroid. 7th ed. Philadelphia: Lippincott-Raven, 1996: 878-82
46. Brent CA, Larsen PR. Treatment of hypothyroidism. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's the thyroid. 8th ed. Philadelphia: Lippincott-Raven, 2000: 853-8
47. Niepomniszcze H, Huaier AR. Skin disorders and thyroid diseases. J Endocrinol Invest 2001; 24: 628-38
48. Lutfi RJ, Fridmanis M, Misiunas AL, et al. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab 1985; 61 (1): 28-31
49. Hegedus L, Heidenheim M, Gervil M, et al. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol 1994; 74: 120-3
50. McDonagh AJ, Messenger AG. The pathogenesis of alopecia areata. Dermatol Clin 1996; 14: 661-70
51. Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989; 84 (1): 66-71
52. Rumbyrt JS, Katz JL, Schocket AL. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol 1995; 96 (6): 901-5
53. Orgiazzi J. Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin North Am 2000; 29 (2): 339-55
54. Findling JW, Aron DC, Tyrrell JB. Glucocrticoids and adrenal androgens. In: Greenspan FS, Strewler GJ, editors. Basic & clinical endocrinology. 5th ed. Connecticut: Appleton & Lange, 1997: 343-54
55. Findling JW, Raff H. Diagnosis and differential diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 2001; 30 (3): 729-47
56. Yanovski JA, Cutler GB. Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin North Am 1994; 23 (3): 487-509
57. Panzer SW, Patrinely JR, Wilson HK. Exophthalmos and iatrogenic Cushing's syndrome. Ophthal Plast Reconstr Surg 1994; 10 (4): 278-82
58. Fisher B, Maibach HF. The effect of corticosteroids on human epidermal mitotic activity. Arch Dermatol 1971; 103: 39-43
59. Rokowski K, Sheehy J, Cutroneo KR. Glucocorticoid-mediated selective reduction of functioning collagen messenger ribonucleic acid. Arch Biochem Biophys 1981; 210: 74-7
60. Ferguson JK, Donald RA, Wetson TS, et al. Skin thickness in patients with acromegaly and Cushing's syndrome and response to treatment. Clin Endocrinol 1983; 18 (4): 347-53
61. Orth DN, Kovacs WJ. The adrenal cortex. In: Wilson JD, Foster DW, Kronenberg HM, et al, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998: 565-9
62. Matsuoka LY, Gavin JR, Goldman J. Spectrum of endocrine abnormalities associated with acanthosis nigricans. Am J Med 1987; 83: 719-25
63. Winkelmann RK, Scheen RS, Underhal LO. Acanthosis nigricans and endocrine disease. JAMA 1960; 174 (9): 1145-52
64. Findling JW, Raff H. Newer diagnostic techniques and problems in Cushing's disease. Endocrinol Metab Clin North Am 1999; 28 (1): 191-210
65. Meier CA, Biller BMK. Clinical and biochemical evaluation of Cushing's syndrome. Endocrinol Metab Clin North Am 1997; 26 (4): 741-62
66. Oelkers W. Adrenal insufficiency: current concepts. N Engl J Med 1996; 335 (16): 1206-12
67. Findling JW, Aron DC, Tyrrell JB. Disorders of adrenocortical insufficiency. In: Greenspan FS, Strewler GJ, editors. Basic & clinical endocrinology. 5th ed. Connecticut: Appleton & Lange, 1997: 334-43
68. Dunlop D. Eighty-six cases of Addison's disease. BMJ 1963; 1: 887-91
69. Barnett AH, Espiner EA, Donald RA. Patients presenting with Addison's need not be pigmented. Postgrad Med J 1982; 58: 690-2
70. Soffer LJ, Dorfman RI, Gabrilove JL. The human adrenal gland. Philadelphia: Lea and Febiger, 1961: 256-75
71. Mountjoy KG. The human melanocyte stimulating hormone receptor has evolved to become "super-sensitive" to melanocortin peptides. Mol Cell Endocrinol 1994; 102 (1-2): R7-11
72. Hunt G, Todd C, Kyne S, et al. ACTH stimulates melanogenesis in cultured human melanocytes. J Endocrinol 1994; 140 (1): R1-3
73. Parker LN. Addison's disease and Cushing's syndrome. In: Parker LN, editor. Adrenal androgens in clinical medicine. San Diego: Academic Press, 1989: 158-74
74. Zelissen PMJ, Bast EJEG, Croughs RJM. Associated autoimmunity in Addison's disease. J Autoimmun 1995; 8: 121-30
75. Grinspoon SK, Biller BM. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994; 79: 923-31
76. Malchoff CD, Carey RM. Adrenal insufficiency. In: Bardin CW, editor Current therapy in endocrinology and metabolism. 6th ed. St Louis: Mosby-Year Book Inc, 1997: 142-6
77. Thorner MO, Vance ML, Laws ER, et al. The anterior pituitary. In: Wilson JD, Foster DW, Kronenberg HM, et al, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998: 295-307
78. Melmed S. Clinical manifestations of acromegaly. UpToDate 1998; 6 (1): 1-5
79. Davidoff LM. Studies in acromegaly: III. the anamnesis ans symptomatology in one hundred cases. Endocrinology 1926; 10: 461-83
80. Brown J, Winkelmann RK. Acanthosis nigricans: a study of 90 cases. Medicine 1968; 47 (1): 33-51
81. Melmed S. Diagnosis of acromegaly. UpToDate 1997; 6 (1): 1-4
82. Ezzat S. Acromegaly. Endocrinol Metab Clin North Am 1997; 26 (4): 703-23
83. Carr BR. Disorders of the ovaries and female reproductive tract. In: Wilson JD, Foster DW, Kronenberg HM, et al, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998: 795-9
84. Taylor AE. Polycystic ovary syndrome. Endocrinol Metab Clin North Am 1008; 27 (4): 877-902
85. Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333 (13): 853-61
86. Vance ML. Hypopituitarism. N Engl J Med 1994; 330 (23): 1651-62
87. Dagher HN, Aboujaoude ZC, Jabbour SA. Chronic urticaria: an unusual initial manifestation of primary hyperparathyroidism. Endocr Pract 2002; 8 (1): 47-9
88. Goltzman D. Hypoparathyroidism. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 3rd ed. Philadelphia: Lippincott-Raven, 1996: 220-3
89. Strewler GJ. Mineral metabolism & metabolic bone disease. In: Greenspan FS, Strewler GJ, editors. Basic & clinical endocrinology. 5th edn. Connecticut: Appleton & Lange, 1997: 288-9
90. Sutphin A, Fuller A, McCune DJ. Five cases (three in siblings) of idiopathic hypoparathyroidism associated with moniliasis. J Clin Endocrinol 1943; 3: 625-34
91. Bilezikian JP. Primary hyperparathyroidism: when to observe and when to operate. Endocrinol Metab Clin North Am 2000; 29 (3): 465-78
92. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998; 21 (S1): S5-S19
93. Muller SA, Winkelman RK. Necrobiosis lipoidica diabeticorum, a clinical and pathological investigation of 171 cases. Arch Dermatol 1966; 93 (3): 272-81
94. Cruz PD, Hud JA. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans. J Invest Dermatol 1992; 98 (6 Suppl.): 82S-5S
95. Matsuoka LY, Wortsman J, Goldman J. Acanthosis nigricans. Clin Dermatol 1993; 11: 21-5
96. Macaron C, Winter RJ, Traisman HS, et al. Vitiligo and juvenile diabetes mellitus. Arch Dermatol 1977; 113 (11): 1515-7
97. Dawber RPR. Vitiligo in mature-onset diabetes. Br J Dermatol 1968; 80 (5): 275-8
98. Stawiski MA, Voorhees JJ. Cutaneous signs of diabetes mellitus. Cutis 1976; 18 (3): 415-21
99. Fleischmajor R, Lara JV. Scleredema adultorum: a histochenical and biochemical study. Arch Dermatol 1965; 92: 643-52
100. Cohen BA, Wheeler CE, Briggman RA. Scleredema of Buschke and diabetes mellitus. Arch Dermatol 1970; 101: 27-35
101. Clark CV, Pentland B, Ewing DJ, et al. Decreased skin wrinkling in diabetes mellitus. Diabetes Care 1984; 7 (3): 224-7
102. Lithner F. Lesions of the legs in diabetics and in patients with familial amyloidosis and polyneuropathy. Acta Med Scand Suppl 1976; 589: 1-23
103. McCulloch DK. Basic insulin regimens in diabetes mellitus. UpToDate 2003; 11 (1): 1-6
104. Jabbour SA, Goldstein BJ. Improving disease management with new treatments for type 2 diabetes mellitus. Clin Geriatr 2001; 9 (5): 157-68